Patents by Inventor Sverker Ljunghall

Sverker Ljunghall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES
    Publication number: 20140256632
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 11, 2014
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjorgen
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 8765674
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: July 1, 2014
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES
    Publication number: 20120148684
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: February 24, 2012
    Publication date: June 14, 2012
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjögren
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 8153588
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: April 10, 2012
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjögren
  • METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES
    Publication number: 20110071081
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: June 23, 2010
    Publication date: March 24, 2011
    Applicant: NPS PHARMACEUTICALS, INC.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjögren
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 7749543
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: July 6, 2010
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES
    Publication number: 20090118192
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: January 9, 2009
    Publication date: May 7, 2009
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 7507715
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: March 24, 2009
    Assignee: NPS Allelix Corp.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • Methods useful in the treatment of bone resorption diseases
    Publication number: 20060211613
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: December 19, 2005
    Publication date: September 21, 2006
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 7018982
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: March 28, 2006
    Assignee: NPS Allelix Corp.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjögren
  • Methods useful in the treatment of bone resorption diseases
    Publication number: 20030162716
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: March 18, 2003
    Publication date: August 28, 2003
    Applicant: NPS ALLELIX CORP.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • Pharmaceutical use
    Publication number: 20020002135
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Application
    Filed: August 31, 2001
    Publication date: January 3, 2002
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjogren
  • Methods useful in the treatment of bone resorption diseases
    Patent number: 6284730
    Abstract: The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: September 4, 2001
    Assignee: NPS Allelix Corp.
    Inventors: John Dietrich, Sverker Ljunghall, Sven Sjögren